(Q37783198)

23 August 2017

1 reference

title

Atrial fibrillation. The therapeutic options (English)

1 reference

23 August 2017

0 references

Lewis RV

1

1 reference

23 August 2017

1 December 1990

1 reference

23 August 2017

1 reference

23 August 2017

40

1 reference

23 August 2017

6

1 reference

23 August 2017

841-853

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199040060-00006

23 August 2017

0 references

cites work

Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation

1 reference

12 December 2020

ATRIAL CONTRIBUTION TO CARDIAC OUTPUT IN COMPLETE HEART BLOCK

1 reference

12 December 2020

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

12 December 2020

Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation

1 reference

12 December 2020

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects

1 reference

12 December 2020

Perceived exertion and gas exchange after calcium and beta-blockade in atrial fibrillation

1 reference

12 December 2020

Usefulness of propafenone for recurrent paroxysmal atrial fibrillation

1 reference

12 December 2020

Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group

1 reference

12 December 2020

Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response

1 reference

12 December 2020

Echocardiographic features of atrioventricular and ventriculoatrial conduction

1 reference

12 December 2020

The relative effects of digoxin and diltiazem upon ventricular ectopic activity in patients with chronic atrial fibrillation

1 reference

12 December 2020

Verapamil-induced ventricular regularity in atrial fibrillation. Effects of exercise, isoproterenol, atropine and conversion to sinus rhythm

1 reference

12 December 2020

Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

12 December 2020

A comparison of verapamil and digoxin in the treatment of atrial fibrillation

1 reference

12 December 2020

Propafenone for prevention of recurrent atrial fibrillation

1 reference

12 December 2020

Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation

1 reference

12 December 2020

Effects of flecainide on the atrial defibrillation threshold

1 reference

12 December 2020

Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation

1 reference

12 December 2020

Misuse of verapamil in pre-excited atrial fibrillation

1 reference

12 December 2020

Electrophysiologic effects, efficacy and tolerance of class Ic antiarrhythmic agents in Wolff-Parkinson-White syndrome

1 reference

12 December 2020

A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation

1 reference

12 December 2020

Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias

1 reference

12 December 2020

Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

1 reference

12 December 2020

1 reference

12 December 2020

Long-term efficacy of flecainide in paroxysmal atrial fibrillation.

1 reference

12 December 2020

Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study

1 reference

12 December 2020

The effect of different digoxin doses on subjective symptoms and physical working capacity in patients with atrial fibrillation

1 reference

12 December 2020

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

12 December 2020

The rhythm of the heart in active elderly subjects

1 reference

12 December 2020

Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset

1 reference

12 December 2020

Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation

1 reference

12 December 2020

Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation

1 reference

12 December 2020

Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study.

1 reference

12 December 2020

Adverse reactions and interactions with beta-adrenoceptor blocking drugs

1 reference

12 December 2020

The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias

1 reference

12 December 2020

Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem

1 reference

12 December 2020

Efficacy of i.v. amiodarone in converting rapid atrial fibrillation and flutter to sinus rhythm in intensive care patients

1 reference

12 December 2020

Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report

1 reference

12 December 2020

Twenty four hour ambulatory electrocardiography in patients with chronic atrial fibrillation

1 reference

12 December 2020

Effect of disopyramide on initiation of atrial fibrillation and relation to effective refractory period

1 reference

12 December 2020

Doppler echocardiographic predictors of recurrence of atrial fibrillation after cardioversion

1 reference

12 December 2020

Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias

1 reference

12 December 2020

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

1 reference

12 December 2020

Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?

1 reference

12 December 2020

Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?

1 reference

12 December 2020

Lessons from ambulatory electrocardiography

1 reference

12 December 2020

Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy

1 reference

12 December 2020

Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial

1 reference

12 December 2020

Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm

1 reference

12 December 2020

The role of inotropic variation in ventricular function during atrial fibrillation

1 reference

12 December 2020

Mechanism of Action of Calcium-Channel-Blocking Agents

1 reference

12 December 2020

10.2165/00003495-199040060-00006

Identifiers

DOI

1 reference

PubMed ID

2078999

Dimensions Publication ID

23 August 2017

0 references

1 reference

PubMed ID

2078999